BERSANI, Samantha
 Distribuzione geografica
Continente #
EU - Europa 2.864
NA - Nord America 2.633
AS - Asia 1.724
SA - Sud America 232
AF - Africa 53
OC - Oceania 5
Totale 7.511
Nazione #
US - Stati Uniti d'America 2.551
RU - Federazione Russa 991
SG - Singapore 644
GB - Regno Unito 557
IT - Italia 512
CN - Cina 470
BR - Brasile 188
DE - Germania 158
HK - Hong Kong 157
VN - Vietnam 147
SE - Svezia 124
BD - Bangladesh 111
FI - Finlandia 104
FR - Francia 102
IE - Irlanda 91
NL - Olanda 70
CA - Canada 45
KR - Corea 45
IN - India 33
AT - Austria 28
ES - Italia 28
UA - Ucraina 26
JP - Giappone 24
MX - Messico 22
IQ - Iraq 19
AR - Argentina 16
BE - Belgio 14
NG - Nigeria 14
PL - Polonia 13
TR - Turchia 13
ID - Indonesia 12
TG - Togo 12
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
CH - Svizzera 7
CL - Cile 7
MA - Marocco 7
VE - Venezuela 7
BJ - Benin 6
JO - Giordania 6
AU - Australia 5
CO - Colombia 5
LT - Lituania 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
IR - Iran 4
PY - Paraguay 4
AL - Albania 3
CR - Costa Rica 3
HR - Croazia 3
KG - Kirghizistan 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
DZ - Algeria 2
EC - Ecuador 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PK - Pakistan 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.510
Città #
Southend 462
Dallas 365
Singapore 362
Moscow 350
Ashburn 293
San Jose 243
Chandler 211
Hong Kong 154
Jacksonville 144
Verona 137
Ann Arbor 130
Beijing 101
Woodbridge 101
Council Bluffs 95
Dublin 85
New York 71
The Dalles 68
Houston 56
Munich 56
Los Angeles 51
Hanoi 43
Ho Chi Minh City 40
Helsinki 39
Shenyang 29
Buffalo 27
Lawrence 27
Princeton 27
Nanjing 25
Madrid 24
Rome 24
Changsha 22
Santa Clara 22
Wilmington 22
Tokyo 20
Hebei 19
London 19
Jinan 18
Orem 18
Tianjin 17
Brescia 16
Guangzhou 16
Milan 16
São Paulo 16
Frankfurt am Main 15
Vienna 15
Abuja 14
Brussels 14
Denver 14
Montreal 13
Ningbo 13
Redondo Beach 13
Turku 13
Warsaw 13
Boardman 12
Lomé 12
Stockholm 12
Amsterdam 10
Bologna 10
Mexico City 10
Nuremberg 10
Sindelfingen 10
Brooklyn 9
Chicago 9
Columbus 9
Toronto 9
Chennai 8
Dearborn 8
Fuzhou 8
Haikou 8
Lappeenranta 8
Paris 8
Poplar 8
Seattle 8
Shanghai 8
Zhengzhou 8
Newark 7
Ankara 6
Baghdad 6
Barnet 6
Cotonou 6
Manchester 6
Piscataway 6
Redmond 6
San Francisco 6
Seoul 6
Taizhou 6
Tashkent 6
Augusta 5
Belo Horizonte 5
Boston 5
Brno 5
Curitiba 5
Falkenstein 5
Kyiv 5
Nanchang 5
Norwalk 5
Ottawa 5
Salvador 5
Amman 4
Aparecida de Goiânia 4
Totale 4.556
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 378
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 287
Whole-genome landscape of pancreatic neuroendocrine tumours 281
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 259
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 233
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 228
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 216
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 213
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 212
Chromosome 3p alterations in pancreatic endocrine neoplasia 204
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 201
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 194
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 192
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 192
Molecular characterization of Pancreatic NeuroEndocrine Tumors (PanNETs) 190
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 185
Author Correction: The landscape of viral associations in human cancers 183
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 183
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 181
Divergent mutational processes distinguish hypoxic and normoxic tumours 180
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 180
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 177
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 166
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting 161
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 161
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior 153
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 143
Combined burden and functional impact tests for cancer driver discovery using DriverPower 137
Author Correction: Pan-cancer analysis of whole genomes 137
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma 133
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 130
Comprehensive molecular characterization of mitochondrial genomes in human cancers 129
Integrative pathway enrichment analysis of multivariate omics data 128
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 120
The landscape of viral associations in human cancers 115
FISH Scoring on Paraffin Sections Versus Single-cell Suspension for Chromophobe Renal Carcinoma and Renal Oncocytoma 110
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 101
Genomic footprints of activated telomere maintenance mechanisms in cancer 88
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig 86
Inferring structural variant cancer cell fraction 67
High fidelity of Claudin-18.2 expression in primary and matched metastatic (lymph nodes, peritoneum, and liver) pancreatic ductal adenocarcinoma: a foundation for targeted therapy 27
Totale 7.580
Categoria #
all - tutte 22.683
article - articoli 20.884
book - libri 0
conference - conferenze 1.349
curatela - curatele 0
other - altro 450
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022277 26 100 14 34 8 4 4 16 6 5 21 39
2022/2023542 43 77 44 87 56 133 3 29 56 0 9 5
2023/2024381 12 15 29 40 22 61 4 51 27 33 64 23
2024/20251.187 59 53 76 156 57 58 91 67 144 78 144 204
2025/20263.660 240 166 348 559 863 221 298 170 316 215 104 160
Totale 7.580